Angelica Belo is a Gastroenterology physician. OpenAlex indexes 10 publications with 299 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
815 S Washington Ave
Suite 201
Marshall, TX 756705369
Telephone
903-927-6880Registry record last updated 10 Jan 2013.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Olympus America Inc.Program year20241 payment
- Gilead Sciences, Inc.Program year20241 payment
- Gilead Sciences, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
91.5%Proton pump inhibitor50.4%Pantoprazole Sodium70%Omeprazole27%Esomeprazole Magnesium4%Part D<11 patientsOsmotic Laxative12.8%Gavilyte-C73%Lactulose16%Gavilyte-G11%Part D≥81 patients+ 9 more classes in this area
Anti-infectives
3%Fluoroquinolone Antibacterial1.7%Levofloxacin100%Part D≥15 patientsNitroimidazole Antimicrobial1.3%Metronidazole100%Part D≥12 patientsCardiovascular
2.4%Bile Acid Sequestrant2.4%Colestipol Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Muscarinic receptor agonists stimulate human colon cancer cell migration and invasion
American Journal of Physiology-Gastrointestinal and Liver Physiology
2011 - Muscarinic receptor agonists stimulate matrix metalloproteinase 1-dependent invasion of human colon cancer cells
Biochemical and Biophysical Research Communications
2011 - Scopolamine Treatment and Muscarinic Receptor Subtype-3 Gene Ablation Augment Azoxymethane-Induced Murine Liver Injury
Journal of Pharmacology and Experimental Therapeutics
2010
Similar KOLs
Other experts from the same institution or the same specialty.
Josep M. Llovet
Institució Catalana de Recerca i Estudis Avançats
Joseph J.�Y. Sung
Nanyang Technological University
Neeraj Bhala
The Royal Melbourne Hospital
Jordi Bruix
Hospital Clínic de Barcelona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”